Contribution of endothelium-derived hyperpolarizing factor to exercise-induced vasodilation in health and hypercholesterolemia

被引:18
作者
Ozkor, Muhiddin A. [1 ]
Hayek, Salim S. [1 ]
Rahman, Ayaz M. [1 ]
Murrow, Jonathan R. [1 ]
Kavtaradze, Nino [1 ]
Lin, Ji [2 ]
Manatunga, Amita [2 ]
Quyyumi, Arshed A. [1 ]
机构
[1] Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA 30322 USA
[2] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
基金
美国国家卫生研究院;
关键词
endothelial function; endothelium-derived hyperpolarizing factor; exercise; hypercholesterolemia; nitric oxide; vasodilation; ACTIVATED POTASSIUM CHANNELS; CA2+-ACTIVATED K+ CHANNELS; FOREARM RESISTANCE VESSELS; HUMAN SKELETAL-MUSCLE; NITRIC-OXIDE; BLOOD-FLOW; DYNAMIC EXERCISE; IN-VIVO; DEPENDENT HYPERPOLARIZATION; TETRAETHYLAMMONIUM IONS;
D O I
10.1177/1358863X14565374
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The role of endothelium-derived hyperpolarizing factor (EDHF) in either the healthy circulation or in those with hypercholesterolemia is unknown. In healthy and hypercholesterolemic subjects, we measured forearm blood flow (FBF) using strain-gauge plethysmography at rest, during graded handgrip exercise, and after sodium nitroprusside infusion. Measurements were repeated after l-NMMA, tetraethylammonium (TEA), and combined infusions. At rest, l-NMMA infusion reduced FBF in healthy but not hypercholesterolemic subjects. At peak exercise, vasodilation was lower in hypercholesterolemic compared to healthy subjects (274% vs 438% increase in FBF, p=0.017). TEA infusion reduced exercise-induced vasodilation in both healthy and hypercholesterolemic subjects (27%, p<0.0001 and -20%, p<0.0001, respectively). The addition of l-NMMA to TEA further reduced FBF in healthy (-14%, p=0.012) but not in hypercholesterolemic subjects, indicating a reduced nitric oxide and greater EDHF-mediated contribution to exercise-induced vasodilation in hypercholesterolemia. In conclusion, exercise-induced vasodilation is impaired and predominantly mediated by EDHF in hypercholesterolemic subjects. Clinical Trial Registration Identifier: NCT00166166
引用
收藏
页码:14 / 22
页数:9
相关论文
共 52 条
[1]   Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide [J].
AlonsoGalicia, M ;
Drummond, HA ;
Reddy, KK ;
Falck, JR ;
Roman, RJ .
HYPERTENSION, 1997, 29 (01) :320-325
[2]   RAT MUSCLE BLOOD FLOWS DURING HIGH-SPEED LOCOMOTION [J].
ARMSTRONG, RB ;
LAUGHLIN, MH .
JOURNAL OF APPLIED PHYSIOLOGY, 1985, 59 (04) :1322-1328
[3]   Calcium-activated potassium channels and NO regulate human peripheral conduit artery mechanics [J].
Bellien, J ;
Joannides, R ;
Iacob, M ;
Arnaud, P ;
Thuillez, C .
HYPERTENSION, 2005, 46 (01) :210-216
[4]   Nitric oxide synthase inhibition reduces leg glucose uptake but not blood flow during dynamic exercise in humans [J].
Bradley, SJ ;
Kingwell, BA ;
McConell, GK .
DIABETES, 1999, 48 (09) :1815-1821
[5]   α-adrenergic vasoconstriction is active skeletal muscles during dynamic exercise [J].
Buckwalter, JB ;
Clifford, PS .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1999, 277 (01) :H33-H39
[6]   Sympathetic vasoconstriction in active skeletal muscles during dynamic exercise [J].
Buckwalter, JB ;
Mueller, PJ ;
Clifford, PS .
JOURNAL OF APPLIED PHYSIOLOGY, 1997, 83 (05) :1575-1580
[7]   EDHF:: bringing the concepts together [J].
Busse, R ;
Edwards, G ;
Félétou, M ;
Fleming, I ;
Vanhoutte, PM ;
Weston, AH .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (08) :374-380
[8]   Role of cyclooxygenase products in the regulation of vascular tone and in the endothelial vasodilator function of normal, hypertensive, and hypercholesterolemic humans [J].
Campia, U ;
Choucair, WK ;
Bryant, MB ;
Quyyumi, AA ;
Cardillo, C ;
Panza, JA .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (03) :286-290
[9]   Vasodilatory mechanisms in contracting skeletal muscle [J].
Clifford, PS ;
Hellsten, Y .
JOURNAL OF APPLIED PHYSIOLOGY, 2004, 97 (01) :393-403
[10]   Endothelial potassium channels, endothelium-dependent hyperpolarization and the regulation of vascular tone in health and disease [J].
Coleman, HA ;
Tare, M ;
Parkington, HC .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2004, 31 (09) :641-649